Carvell Nguyen
Urology · Cleveland, OHNPI 1831381482
Payments from drug & device makers
Across 52 payments — averaging $465.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$24K
- Angiodynamics, Inc.$348
- Dornier Medtech America, Inc$60
- AstraZeneca$35
- C. R. Bard, Inc. & Subsidiaries$35
- Procept Biorobotics Corporation$17
- plus $15 from 1 others
What the payments were for
- Speaking & faculty fees$5502%
- Travel & lodging$4,21417%
- Food & beverage$1,9028%
- Education$17,53572%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 42 | $23,691 |
| Angiodynamics, Inc. | 5 | $348 |
| Dornier Medtech America, Inc | 1 | $60 |
| AstraZeneca | 1 | $35 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $35 |
| Procept Biorobotics Corporation | 1 | $17 |
| BD | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$21,768
- DA VINCI SP$1,500
- Nanoknife$125
How this compares
$24,201 in reported general payments places this provider in the 85th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lupron DepotLeuprolide Acetate | 17 | $202,950 |
| MyrbetriqMirabegron | 131 | $69,851 |
| GemtesaVibegron | 16 | $13,256 |
| Tamsulosin Hcl | 631 | $7,728 |
| Trospium Chloride | 39 | $2,516 |
| Finasteride | 273 | $2,400 |
| Oxybutynin Chloride ErOxybutynin Chloride | 47 | $788 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 57 | $652 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 32 | $600 |
| Sildenafil Citrate | 29 | $507 |
| Terazosin Hcl | 13 | $348 |
| Solifenacin Succinate | 13 | $284 |
| Megestrol Acetate | 14 | $238 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 61 | $206 |
| Ciprofloxacin Hcl | 19 | $88 |
Paid to pharmacies, not to this prescriber.
Other urology in Cleveland
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
- Petar BajicCleveland$321K
- Sriharan SivalingamCleveland$282K
- Adonis HijazCleveland$263K
- Ruben OlivaresCleveland$184K
- Ahmed AboumohamedCleveland$139K
- Jorge Gutierrez AcevesCleveland$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.